Abbott India Limited Abbott India Limited

Abbott India Limited

ABBOTINDIA

Hisse Senetlerindeki Sıralama #3030
Abbott India Limited is a pharmaceutical enterprise that conducts its... Abbott India Limited is a pharmaceutical enterprise that conducts its operations across India. The company provides an extensive portfolio of medicinal products designed for a broad spectrum of therapeutic areas, including women's health, digestive conditions, metabolic disorders, central nervous system ailments, pain management, premature labor concerns, vitamin supplementation, sleep aids, immunizations, and general consumer health items. Established in 1944, the firm was formerly known as Knoll Pharmaceuticals Limited until it officially adopted the name Abbott India Limited in July 2002. Headquartered in Mumbai, India, it operates as a subsidiary of Abbott Capital India Limited.
Hisse Fiyatı
$285.00
Piyasa Değeri
$6.06B
Değişim (1 gün)
-0.31%
Değişim (1 yıl)
-17.08%
Ülke
IN
Ticaret Abbott India Limited (ABBOTINDIA)

Kategori

Healthcare
Abbott India Limited (ABBOTINDIA) için kazanç
Jun 2026 itibarıyla kazanç TTM: $238.19M
Abbott India Limited şirketinin en son finansal raporlarına göre, mevcut kazancı $238.19M'dir. 2024 yılında şirket $194.01M kazanç elde etti, bu 2023 yılındaki $155.00M kazanca göre önceki yıla göre artış. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Abbott India Limited için kazanç geçmişi 2004 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
2026 (TTM) $238.19M 7.96%
2025 $220.63M 13.72%
2024 $194.01M 25.17%
2023 $155.00M 8.97%
2022 $142.24M 12.45%
2021 $126.49M 18.71%
2020 $106.55M 5.87%
2019 $100.64M 5.44%
2018 $95.45M 41.81%
2017 $67.31M 12.04%
2016 $60.08M 8.86%
2015 $55.19M 39.00%
2014 $39.70M 1.44%
2012 $39.14M 15.33%
2011 $33.94M 61.11%
2010 $21.06M -16.67%
2009 $25.28M 33.27%
2008 $18.97M -26.36%
2007 $25.76M 31.50%
2006 $19.59M 3.19%
2005 $18.98M -38.51%
2004 $30.87M 0.00%
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
$33.60B 14,004.37%
US
$17.74B 7,346.49%
US
$8.70B 3,552.08%
US
$5.95B 2,397.14%
US
$21.39B 8,879.40%
CH